Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Katzenstein

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
Infectious Diseases (London, England)|August 10, 2021
Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2Camilla Heldbjerg Drabe, Ann-Brit Eg Hansen, Line Dahlerup Rasmussen, et al.
BMC Infectious Diseases|June 3, 2014
Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general populationKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Infectious Diseases (London, England)|May 11, 2016
Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-BissauAllan Sørensen, Sanne Jespersen, Terese L Katzenstein, et al.
The New England Journal of Medicine|February 22, 1990
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasiaR G Knowlton, P L Katzenstein, R W Moskowitz, et al.
The American Journal of Surgical Pathology|November 1, 1995
Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infectionJ L Myers, P J Kurtin, A L Katzenstein, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
Pediatric Pulmonology|October 31, 2022
Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantationMatilde B Ørum, Frederikke F Rönsholt, Majbritt Jeppesen, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.
Journal of Virus Eradication|August 1, 2017
HIV disclosure and stigma among women living with HIV in DenmarkMaria Wessman, Kristina Thorsteinsson, Merete Storgaard, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Infectious Diseases (London, England)|August 10, 2021
Low morbidity in Danish patients with common variable immunodeficiency disorder infected with severe acute respiratory syndrome coronavirus 2Camilla Heldbjerg Drabe, Ann-Brit Eg Hansen, Line Dahlerup Rasmussen, et al.
BMC Infectious Diseases|June 3, 2014
Adherence to the cervical cancer screening program in women living with HIV in Denmark: comparison with the general populationKristina Thorsteinsson, Steen Ladelund, Søren Jensen-Fangel, et al.
Infectious Diseases (London, England)|May 11, 2016
Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-BissauAllan Sørensen, Sanne Jespersen, Terese L Katzenstein, et al.
The New England Journal of Medicine|February 22, 1990
Genetic linkage of a polymorphism in the type II procollagen gene (COL2A1) to primary osteoarthritis associated with mild chondrodysplasiaR G Knowlton, P L Katzenstein, R W Moskowitz, et al.
The American Journal of Surgical Pathology|November 1, 1995
Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infectionJ L Myers, P J Kurtin, A L Katzenstein, et al.
Archives of Internal Medicine|May 2, 2000
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyR Paredes, A Mocroft, O Kirk, et al.
Pediatric Pulmonology|October 31, 2022
Outcome of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis and solid organ transplantationMatilde B Ørum, Frederikke F Rönsholt, Majbritt Jeppesen, et al.
AIDS (London, England)|November 14, 1998
Changes in use of antiretroviral therapy in regions of Europe over time. EuroSIDA Study GroupO Kirk, A Mocroft, T L Katzenstein, et al.
HIV Medicine|September 17, 2004
Resistance profiles and adherence at primary virological failure in three different highly active antiretroviral therapy regimens: analysis of failure rates in a randomized studyB T Røge, T S Barfod, O Kirk, et al.
Journal of Virus Eradication|August 1, 2017
HIV disclosure and stigma among women living with HIV in DenmarkMaria Wessman, Kristina Thorsteinsson, Merete Storgaard, et al.
Pageof 24